Asset Details
Do you wish to reserve the book?
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Do you wish to request the book?
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
2019
Overview
Profound global loss of DNA methylation is a hallmark of many cancers. One potential consequence of this is the reactivation of transposable elements (TEs) which could stimulate the immune system via cell-intrinsic antiviral responses. Here, we develop
REdiscoverTE
, a computational method for quantifying genome-wide TE expression in RNA sequencing data. Using The Cancer Genome Atlas database, we observe increased expression of over 400 TE subfamilies, of which 262 appear to result from a proximal loss of DNA methylation. The most recurrent TEs are among the evolutionarily youngest in the genome, predominantly expressed from intergenic loci, and associated with antiviral or DNA damage responses. Treatment of glioblastoma cells with a demethylation agent results in both increased TE expression and de novo presentation of TE-derived peptides on MHC class I molecules. Therapeutic reactivation of tumor-specific TEs may synergize with immunotherapy by inducing inflammation and the display of potentially immunogenic neoantigens.
Treatment with demethylation agents can reactivate transposable elements. Here in glioblastoma, the authors also show that this is accompanied by de novo presentation of TE-derived peptides on MHC class I molecules.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 45
/ 45/91
/ Antigens, Neoplasm - genetics
/ Antigens, Neoplasm - immunology
/ Antigens, Neoplasm - metabolism
/ Computational Biology - methods
/ DNA
/ DNA Methylation - immunology
/ DNA Transposable Elements - genetics
/ DNA Transposable Elements - immunology
/ Gene Expression - immunology
/ Genomes
/ Humanities and Social Sciences
/ Humans
/ Major histocompatibility complex
/ Peptides
/ RNA
/ Science
/ Tumors
